Showing results (251-260 of 268) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy StudyF García, M M Alonso, J Romeu, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in SpainM Diez, A Diaz, M J Bleda, et al.
Antiviral Therapy|July 19, 2005
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-upE Negredo, R Paredes, A Bonjoch, et al.
HIV Medicine|December 23, 2017
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohortA Roen, K Laut, A Pelchen-Matthews, et al.
HIV Medicine|March 30, 2010
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditionsR Rubio, O Serrano, J Carmena, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patientsK Van Laethem, J C Schmit, H Pelemans, et al.
The Lancet. Infectious Diseases|March 25, 2011
European guidelines on the clinical management of HIV-1 tropism testingL P R Vandekerckhove, A M J Wensing, R Kaiser, et al.
HIV Medicine|January 15, 2015
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort dataJ Vingerhoets, V Calvez, P Flandre, et al.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patientsD Podzamczer, A Imaz, I Perez, et al.
Pageof 27